52 related articles for article (PubMed ID: 16038261)
1. [NQ01 gene polymorphism C609T associated with an increased risk for cognitive dysfunction and sporadic Alzheimer's disease in Chinese].
Wan HY; Chen B; Yang JF; Dong XM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun; 27(3):285-8. PubMed ID: 16038261
[TBL] [Abstract][Full Text] [Related]
2. [Association between NAD(P)H: quinone oxidoreductase and apolipoprotein E gene polymorphisms in Alzheimer's disease].
Ma QL; Yang JF; Shao M; Dong XM; Chen B
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2124-7. PubMed ID: 14720419
[TBL] [Abstract][Full Text] [Related]
3. [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer].
Zhang JH; Li Y; Wang R; Sarbia M; Guo W; Wen DG; Wei LZ; Chen ZF; Kuang G; Zhang LW; He M; Wu ML; Wang SJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):544-6. PubMed ID: 14669229
[TBL] [Abstract][Full Text] [Related]
4. Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease.
Wang B; Jin F; Xie Y; Tang Y; Kan R; Zheng C; Yang Z; Wang L
Neurosci Lett; 2006 Dec; 409(3):179-81. PubMed ID: 17027152
[TBL] [Abstract][Full Text] [Related]
5. [A study on the relationship between polymorphism of human NAD(P)H: quinone oxidoreductase and Parkinson's disease in Chinese].
Jiang XH; Yang H; Yang JF; Wang HT; Xu QY; Chen B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):120-3. PubMed ID: 15079792
[TBL] [Abstract][Full Text] [Related]
6. [Study on genetic polymorphism of NQO1 and susceptibility to benzene poisoning].
Chen Y; Ji Z; Xu J; Wu C; Li G
Wei Sheng Yan Jiu; 2004 Nov; 33(6):657-9. PubMed ID: 15727169
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease.
Wang X; DeKosky ST; Luedecking-Zimmer E; Ganguli M; Kamboh MI
Hum Genet; 2002 Apr; 110(4):356-65. PubMed ID: 11941486
[TBL] [Abstract][Full Text] [Related]
8. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
[TBL] [Abstract][Full Text] [Related]
9. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia.
Sirma S; Agaoglu L; Yildiz I; Cayli D; Horgusluoglu E; Anak S; Yuksel L; Unuvar A; Celkan T; Apak H; Karakas Z; Devecioglu O; Ozbek U
Pediatr Blood Cancer; 2004 Oct; 43(5):568-70. PubMed ID: 15382274
[TBL] [Abstract][Full Text] [Related]
10. APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease.
Barabash A; Marcos A; Ancín I; Vázquez-Alvarez B; de Ugarte C; Gil P; Fernández C; Encinas M; López-Ibor JJ; Cabranes JA
Neurobiol Aging; 2009 Aug; 30(8):1254-64. PubMed ID: 18078695
[TBL] [Abstract][Full Text] [Related]
11. Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population.
Xue S; Jia L; Jia J
Neurosci Lett; 2009 Nov; 465(2):181-3. PubMed ID: 19733630
[TBL] [Abstract][Full Text] [Related]
12. Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer.
Ergen HA; Gormus U; Narter F; Zeybek U; Bulgurcuoglu S; Isbir T
Anticancer Res; 2007; 27(6B):4107-10. PubMed ID: 18225579
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive use and breast cancer risk: modification by NAD(P)H:quinone oxoreductase (NQO1) genetic polymorphisms.
Fowke JH; Shu XO; Dai Q; Jin F; Cai Q; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1308-15. PubMed ID: 15298951
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity.
Nacmias B; Bagnoli S; Tedde A; Cellini E; Bessi V; Guarnieri B; Ortensi L; Piacentini S; Bracco L; Sorbi S
Arch Gerontol Geriatr; 2007; 45(2):201-6. PubMed ID: 17182125
[TBL] [Abstract][Full Text] [Related]
15. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease.
Okuizumi K; Onodera O; Namba Y; Ikeda K; Yamamoto T; Seki K; Ueki A; Nanko S; Tanaka H; Takahashi H; Oyanagi K; Mizusawa H; Kanazawa I; Tsuji S
Nat Genet; 1995 Oct; 11(2):207-9. PubMed ID: 7550352
[TBL] [Abstract][Full Text] [Related]
16. The T-786C NOS3 polymorphism in Alzheimer's disease: association and influence on gene expression.
Venturelli E; Galimberti D; Lovati C; Fenoglio C; Scalabrini D; Mariani C; Forloni G; Bresolin N; Scarpini E
Neurosci Lett; 2005 Jul; 382(3):300-3. PubMed ID: 15925107
[TBL] [Abstract][Full Text] [Related]
17. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
Bian JT; Zhang JW; Zhang ZX; Zhao HL
Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
[TBL] [Abstract][Full Text] [Related]
18. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
Cui T; Zhou X; Jin W; Zheng F; Cao X
Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
[TBL] [Abstract][Full Text] [Related]
19. [Association between DLST gene polymorphism and Alzheimer's disease].
Ma Q; Chan P; Yang J
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(20):1246-8. PubMed ID: 11825528
[TBL] [Abstract][Full Text] [Related]
20. The APOE-491 A/T promoter polymorphism effect on cognitive profile of Alzheimer's patients.
Valenza A; Bizzarro A; Marra C; Lauria A; Guglielmi V; Rossi C; Tiziano FD; Brahe C; Masullo C
Neurosci Lett; 2010 Mar; 472(3):199-203. PubMed ID: 20152880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
